Is GERN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GERN. It does not provide personalized investment advice.

GERN (Geron Corp) Stock Analysis - Financials

Geron Corp (GERN) is a publicly traded Healthcare sector company. As of July 13, 2026, GERN trades at $1.45 with a market cap of $962.28M and a P/E ratio of -13.73. GERN moved -3.67% today. Year to date, GERN is +11.94%; over the trailing twelve months it is +8.70%. Its 52-week range spans $1.04 to $4.21. Analyst consensus is strong buy with an average price target of $4.00. Rallies surfaces GERN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are GERN's key financials?

GERN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GERN recently traded at $1.45. Market cap is $962.28M. P/E ratio is -13.73. Revenue is $196.12M.

GERN Key Metrics

Key financial metrics for GERN
Metric	Value
Price	$1.45
Market Cap	$962.28M
P/E Ratio	-13.73
EPS	$-0.11
Dividend Yield	0.00%
52-Week High	$4.21
52-Week Low	$1.04
Volume	3.35M
Avg Volume	0
Revenue (TTM)	$196.12M
Net Income	$-67.31M
Gross Margin	0.00%

GERN Analyst Consensus

4 analysts cover GERN: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.00.

Common questions about GERN

What are GERN's key financials?: GERN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GERN recently traded at $1.45. Market cap is $962.28M. P/E ratio is -13.73. Revenue is $196.12M.
Is GERN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GERN. It does not provide personalized investment advice.